Ribociclib Drug‐Drug Interactions: Clinical Evaluations and Physiologically‐Based Pharmacokinetic Modeling to Guide Drug Labeling
出版年份 2020 全文链接
标题
Ribociclib Drug‐Drug Interactions: Clinical Evaluations and Physiologically‐Based Pharmacokinetic Modeling to Guide Drug Labeling
作者
关键词
-
出版物
CLINICAL PHARMACOLOGY & THERAPEUTICS
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2020-06-19
DOI
10.1002/cpt.1950
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- An integrated assessment of the ADME properties of the CDK4/6 Inhibitor ribociclib utilizing preclinical in vitro, in vivo, and human ADME data
- (2020) Alexander D. James et al. Pharmacology Research & Perspectives
- MONALEESA clinical program: a review of ribociclib use in different clinical settings
- (2019) Denise A Yardley Future Oncology
- Overall Survival with Ribociclib plus Endocrine Therapy in Breast Cancer
- (2019) Seock-Ah Im et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Phase I Study of the Cyclin-Dependent Kinase 4/6 Inhibitor Ribociclib (LEE011) in Patients with Advanced Solid Tumors and Lymphomas
- (2016) J. R. Infante et al. CLINICAL CANCER RESEARCH
- Physiologically based pharmacokinetic modeling in regulatory decision-making at the European Medicines Agency
- (2016) E Luzon et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Understanding Disease-Drug Interactions in Cancer Patients: Implications for Dosing Within the Therapeutic Window
- (2015) DE Coutant et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Quantitative clinical pharmacology for size and age scaling in pediatric drug development: A systematic review
- (2015) Tanay S. Samant et al. JOURNAL OF CLINICAL PHARMACOLOGY
- The Role of CDK4/6 Inhibition in Breast Cancer
- (2015) C. G. Murphy et al. ONCOLOGIST
- Physiologically based pharmacokinetic modeling of CYP3A4 induction by rifampicin in human: Influence of time between substrate and inducer administration
- (2014) Guillaume Baneyx et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- The Utility of Modeling and Simulation in Drug Development and Regulatory Review
- (2013) Shiew-Mei Huang et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- A physiologically based pharmacokinetic (PBPK) approach to evaluate pharmacokinetics in patients with cancer
- (2012) Sravanthi Cheeti et al. BIOPHARMACEUTICS & DRUG DISPOSITION
- Critique of the Two-Fold Measure of Prediction Success for Ratios: Application for the Assessment of Drug-Drug Interactions
- (2010) E. J. Guest et al. DRUG METABOLISM AND DISPOSITION
- Resurgence in the use of physiologically based pharmacokinetic models in pediatric clinical pharmacology: parallel shift in incorporating the knowledge of biological elements and increased applicability to drug development and clinical practice
- (2010) Trevor N. Johnson et al. PEDIATRIC ANESTHESIA
- Pharmacokinetic assessment of a five-probe cocktail for CYPs 1A2, 2C9, 2C19, 2D6 and 3A
- (2009) Sandrine Turpault et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Inhibition of oral midazolam clearance by boosting doses of ritonavir, and by 4,4-dimethyl-benziso-(2H)-selenazine (ALT-2074), an experimental catalytic mimic of glutathione oxidase
- (2009) David J. Greenblatt et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- The Conduct of in Vitro Studies to Address Time-Dependent Inhibition of Drug-Metabolizing Enzymes: A Perspective of the Pharmaceutical Research and Manufacturers of America
- (2009) S. W. Grimm et al. DRUG METABOLISM AND DISPOSITION
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation